GTCR Completes Acquisition of Zentiva

GTCR has completed its acquisition of Zentiva, a European generics pharmaceutical company. The transaction is described as a completed platform acquisition.

The provided material does not include deal consideration, financing terms, or closing conditions beyond the fact that the acquisition has been completed.